Omrix Biopharmaceuticals

Developer of biopharmaceutical products derived from human plasma

placeNess Ziona, Center District, Israel calendar_todayFounded 1995 language omrix.com

Innovation

77 patent families (61 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport, Physics & computing; filing pace slowing. Cited 5,815 times.

YearFilings
201522
201625
201731
201834
201929
202032
202130
202215
202316
202419
202511
20262

Social engagement

Social engagement: 14.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%
Coming soon